| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/23/2004 | EP1429648A2 METHODS FOR SCREENING FOR SUBSTANCES WHICH INHIBIT FP PROSTANOID RECEPTOR INTERACTION WITH A COMPOUND HAVING PGF 2$g(a)alpha?ACTIVITY AND METHODS OF TREATING CANCER |
| 06/23/2004 | EP1429629A1 Compositions for appetite control and related methods |
| 06/23/2004 | EP1429623A1 Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses |
| 06/23/2004 | EP1429617A2 Methods for sterilizing preparations of digestive enzymes |
| 06/23/2004 | EP1342730A4 Fusion protein having the enhanced in vivo activity of erythropoietin |
| 06/23/2004 | EP1265985A4 Pancreatic islet cell growth factors |
| 06/23/2004 | EP1226162A4 Novel molecules of the card-related protein family and uses thereof |
| 06/23/2004 | EP1171573B1 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 06/23/2004 | EP1169470B1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto |
| 06/23/2004 | EP1032671B1 Mammalian cytokine-like polypeptide-10 |
| 06/23/2004 | EP1024801B1 Method for regulating size and growth of vascularized normal tissue |
| 06/23/2004 | EP1003500A4 Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury |
| 06/23/2004 | EP0906340B1 Purification of factor viii complex by immunoaffinity chromatography |
| 06/23/2004 | EP0871471B1 Compositions using morphogenic proteins and stimulatory factors |
| 06/23/2004 | EP0750505B1 Immunotherapy of cancer with allogeneic lymphocytes |
| 06/23/2004 | EP0646176B1 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 06/23/2004 | CN1507492A P18A betar P gene and P18A beta r p protein, novel gene/protein (P60 TRP) interacting therewith to inhibit cell death and cell death promoter |
| 06/23/2004 | CN1507491A Apoptosis promoter and inhibitor interacting with CGI-94 and method of screening the same |
| 06/23/2004 | CN1507456A Fibre containing composition for enteral nutrition |
| 06/23/2004 | CN1507451A Cyclosporin-pro-drug and use thereof as a medicament |
| 06/23/2004 | CN1507362A Method of preventing type 2 diabetes with aerosolized insulin |
| 06/23/2004 | CN1507358A Carrier with solid fibrinogen and solid thrombin |
| 06/23/2004 | CN1507357A Method and compositions for enhanced delivery of bioactive molecules |
| 06/23/2004 | CN1507356A Remedies for sepsis |
| 06/23/2004 | CN1507355A Combination therapy using anti-EGFR antibodies and anti-hormonal agents |
| 06/23/2004 | CN1507347A Coated granules based on angiotensin-converting enzyme inhibitor |
| 06/23/2004 | CN1507339A Use of 3-position cyclosporin derivatives for hair growth |
| 06/23/2004 | CN1506459A Lumbricus kinase of electrophoretical purity and its prepn and use |
| 06/23/2004 | CN1506375A Azurin as bacterial protein with wide-spectrum antitumor function and its use and medicinal composition |
| 06/23/2004 | CN1506116A Process for preparing degradable polymer and medical composition containing the said polymer and use thereof |
| 06/23/2004 | CN1506114A Application of aliphatic diphenol lysine insulin in treating diabetes |
| 06/23/2004 | CN1506113A Prepn process of hydrogel prepn of recombined platelet derived growth factor |
| 06/23/2004 | CN1506112A Hydrogel prepn of recombined platelet derived growth factor |
| 06/23/2004 | CN1506111A Production process of freeze dried scorpion venom polypeptide powder prepn |
| 06/23/2004 | CN1505980A Nutritious composition |
| 06/23/2004 | CN1505979A Nutritious composition |
| 06/23/2004 | CN1505978A Nutritious constituents |
| 06/23/2004 | CN1505977A Nutritious constituents |
| 06/23/2004 | CN1154735C Mammalian gene encoding tolloid protein |
| 06/23/2004 | CN1154729C Staphylokinase derivs |
| 06/23/2004 | CN1154726C OB protein derivatives having prolonged half-life |
| 06/23/2004 | CN1154725C Human bikunin |
| 06/23/2004 | CN1154659C Novel anti-AIDS immunotoxins |
| 06/23/2004 | CN1154658C Process for the purification of glycoproteins like erythropoietin |
| 06/23/2004 | CN1154657C Cyclic peptide analogs of somatostatin |
| 06/23/2004 | CN1154656C Memory-improving peptides and their application |
| 06/23/2004 | CN1154655C K receptor opioid peptides |
| 06/23/2004 | CN1154653C Peptide and method of obtaining it |
| 06/23/2004 | CN1154508C Stimulation of host defence mechanisms against viral challenges |
| 06/23/2004 | CN1154507C Inhibition of binding of Hox and homeodomain containing proteins and uses thereof |
| 06/23/2004 | CN1154506C Method of preventing or treating allergies |
| 06/23/2004 | CN1154492C Medical composition containing pentosan polysulfate and its application |
| 06/23/2004 | CN1154491C Method for improving pharmacokinetics of tipranavir |
| 06/23/2004 | CN1154487C Drugs for reducing vaginal acidity and treatment of vaginitis, and the use thereof |
| 06/22/2004 | US6753431 Production of mixed acid anhydride and amide compound |
| 06/22/2004 | US6753424 Conjugates of DNA interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 06/22/2004 | US6753423 For preferentially modulated gene expression in liver and associated tissues |
| 06/22/2004 | US6753417 Peptide for use in the diagnosis and prevention of immunological and infectious disorders |
| 06/22/2004 | US6753412 Human Eag2 |
| 06/22/2004 | US6753411 Genetic engineering; insertion vector into polypeptides |
| 06/22/2004 | US6753410 Investigational compounds |
| 06/22/2004 | US6753407 Amino acid sequences for endobiotic peptides; detecting freshness and treating stress |
| 06/22/2004 | US6753325 Comprises vitamin d3 for controlling cell differentiation and/or cell proliferation |
| 06/22/2004 | US6753321 Method of modulating neovascularization |
| 06/22/2004 | US6753320 Administering nucleic acid; gene expression |
| 06/22/2004 | US6753317 Dmt-Tic di- and tri-peptide derivatives and related compositions and methods of use |
| 06/22/2004 | US6753315 Locally administering to a cutaneous tissue an isolated native or modified alpha -bungarotoxin molecule (a polypeptide) to enhance denervation of the muscle to enhance relaxation or slackening of the cutaneous tissue |
| 06/22/2004 | US6753314 Protein-protein complexes and methods of using same |
| 06/22/2004 | US6753313 Multimeric Apoa-I agonist compounds |
| 06/22/2004 | US6753312 For administering high levels of plant antioxidants to human and mammals; therapy of diseases |
| 06/22/2004 | US6753311 Collagen or collagen-like peptide containing polymeric matrices |
| 06/22/2004 | US6753310 Neovascular-specific peptides |
| 06/22/2004 | US6753183 Immunologically active proteins from Borrelia burgdorferi |
| 06/22/2004 | US6753176 Genetic engineering; antiarthritic agents |
| 06/22/2004 | US6753175 Antiinflammatory agents; anticancer agents; cardiovascular disorders; genetic engineering; transgenic animals |
| 06/22/2004 | US6753164 Nucleic acids encoding human serpin polypeptide HMCIS41 |
| 06/22/2004 | US6753162 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells |
| 06/22/2004 | US6753151 Interactions of Ku polypeptides and applications thereof |
| 06/22/2004 | US6753140 Nucleotide sequences coding preferential polypeptide for use in the treatment of diabetes and eating disorders |
| 06/22/2004 | US6752996 Adjuvant for poorly immunogenic tumor vaccines and subunit vaccines, such as those for preventing and/or treating flu, tuberculosis, respiratory syncytial virus, anthrax and hiv. |
| 06/22/2004 | US6752995 Nucleic acid and polypeptide sequences useful as adjuvants |
| 06/22/2004 | US6752991 Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor |
| 06/22/2004 | US6752988 Lytic enzyme produced by a bacteria infected with a bacteriophage specific for said bacteria; holin enzymes; hemophilus, streptococcus |
| 06/22/2004 | US6752987 Adenovirus encoding human adenylylcyclase (AC) VI |
| 06/22/2004 | US6752986 Using vitamin b12 compound; controlling gene expression |
| 06/22/2004 | CA2210620C Anti-cd 30 antibodies preventing proteolytic cleavage and release of membrane-bound cd 30 antigen |
| 06/22/2004 | CA2176926C .alpha.v.beta.3 integrin as a predictor of endometriosis |
| 06/22/2004 | CA2117904C Methods and reagents for diagnosis of autoantibodies |
| 06/17/2004 | WO2004051280A2 Identification of agonistic autoantibodies |
| 06/17/2004 | WO2004050907A2 Method for determing predisposition to manifestation of immune system related diseases |
| 06/17/2004 | WO2004050885A2 Control of apoptosis using a complex of an oligonucleotide and a regulatory peptide |
| 06/17/2004 | WO2004050868A1 Novel adaptor protein binding to mammalian toll-like receptor 3 and gene thereof |
| 06/17/2004 | WO2004050846A2 Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines |
| 06/17/2004 | WO2004050844A2 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 06/17/2004 | WO2004050834A2 GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER |
| 06/17/2004 | WO2004050833A2 Glyceraldehyde 3-phosphate dehydrogenase-s(gapds), a glycolytic enzyme expressed only in male germ cells,is a target for male contraception |
| 06/17/2004 | WO2004050832A2 Antimicrobial compounds from bacillus subtilis for use against animal and human pathogens |
| 06/17/2004 | WO2004050828A2 Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer |
| 06/17/2004 | WO2004050706A2 Regulatory t-cells |
| 06/17/2004 | WO2004050704A1 Therapeutic and diagnostic agents |